| 臺大學術典藏 |
2022-02-23T02:12:17Z |
Tenofovir Is Superior to Entecavir on Tertiary Prevention for BCLC Stage 0/A Hepatocellular Carcinoma after Curative Resection
|
Tsai M.-C.; Wang C.-C.; Lee W.-C.; Lin C.-C.; Chang K.-C.; CHIEN-HUNG CHEN; Hung C.-H.; Lin M.-T.; Hsiao C.-C.; Chen C.-L.; Chien R.-N.; Hu T.-H. |
| 臺大學術典藏 |
2022-02-22T05:34:45Z |
Hepatic tumor in fatty liver: Diagnostic difficulty in ultrasonography
|
Wang C.-C.; Huang G.-T.; Yang P.-M.; CHIEN-HUNG CHEN; Sheu J.-C.; Chen D.-S. |
| 臺大學術典藏 |
2022-02-22T05:34:15Z |
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Lu S.-N.; Wang J.-H.; Su C.-W.; Wang T.-E.; Dai C.-Y.; CHIEN-HUNG CHEN; Chen R.-C.; Yang S.-S.; Hung C.-F.; Huang S.-F.; Liao L.-Y.; Huo T.-I.; Wu C.-C.; Lee P.-H.; Ting C.-T.; Lee W.-C.; Chau G.-Y.; Wang C.-C.; Lee K.-T.; Huang Y.-H.; Ho M.-C.; Lin S.-M.; Huang G.-T.; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; Liang P.-C.; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; Cheng A.-L.; Hsu C.; Chao Y.; Chen L.-T.; Wang P.-M.; Wang P.-M.; Hong J.-H.; Hsu H.-C.; Chen S.-W.; Leung S.W.; Cheng J.C.-H.; Wu J.-C.; Wu C.-Y.; Hsu Y.-C.; Hsu C.-W.; Ni Y.-H.; Lin C.-L.; Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group |
| 臺大學術典藏 |
2022-02-22T05:34:10Z |
Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Shao Y.-Y.; Wang S.-Y.; Lin S.-M.; Chen K.-Y.; Tseng J.-H.; Ho M.-C.; Lee R.-C.; Liang P.-C.; Liao L.-Y.; Huang K.-W.; Hu J.-T.; Liang J.-D.; Kee K.-M.; Lin C.-L.; Wang C.-K.; Lu S.-N.; Wang J.-H.; Lee W.-C.; CHIEN-HUNG CHEN; Liu C.-J.; Huang Y.-H.; Wang C.-C.; Wang T.-E.; Chuang P.-H.; Dai C.-Y.; Hsu C.; Chen S.-C.; Hsieh C.-H.; Diagnosis Group, Systemic Therapy Group |
| 臺大學術典藏 |
2022-02-22T05:34:10Z |
Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan
|
Cheng P.-N.; Mo L.-R.; Chen C.-T.; Chen C.-Y.; Huang C.-F.; Kuo H.-T.; Lo C.-C.; Tseng K.-C.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; CHIEN-HUNG CHEN; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Chang T.S.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Chou K.-H.; Kao C.-N.; Tsai P.-C.; Liu C.-H.; Lee M.-H.; Cheng C.-Y.; Tsai M.-C.; Liu C.-J.; Dai C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L.; Yu M.-L.; TACR investigators |
| 臺大學術典藏 |
2022-02-22T05:34:07Z |
Tenofovir Is Superior to Entecavir on Tertiary Prevention for BCLC Stage 0/A Hepatocellular Carcinoma after Curative Resection
|
Tsai M.-C.; Wang C.-C.; Lee W.-C.; Lin C.-C.; Chang K.-C.; CHIEN-HUNG CHEN; Hung C.-H.; Lin M.-T.; Hsiao C.-C.; Chen C.-L.; Chien R.-N.; Hu T.-H. |
| 臺大學術典藏 |
2022-02-22T03:37:25Z |
Narrow-band imaging with magnifying endoscopy for the screening of esophageal cancer in patients with primary head and neck cancers
|
Lee C.T.; Chang C.Y.; Lee Y.C.; Tai C.M.; Wang W.L.; PING-HUEI TSENG; Hwang J.C.; Hwang T.Z.; Wang C.C.; Lin J.-T. |
| 臺大學術典藏 |
2022-02-22T03:37:22Z |
The benefit of pretreatment esophageal screening with image-enhanced endoscopy on the survival of patients with hypopharyngeal cancer
|
Wang W.-L.; Wang C.-P.; Wang H.-P.; Lee C.-T.; Chang C.-Y.; Tai C.-M.; Tseng C.-H.; Hwang T.-Z.; Wang C.-C.; Lo J.-L.; PING-HUEI TSENG; Chiu H.-M.; Lee J.-M.; Ko J.-Y.; Lou P.-J.; Wu M.-S.; Lee Y.-C.; Lin J.-T. |
| 臺大學術典藏 |
2022-02-10T06:51:30Z |
Effect of noisy galvanic vestibular stimulation on dynamic posture sway under visual deprivation in patients with bilateral vestibular hypofunction
|
Chen P.-Y.; Jheng Y.-C.; Wang C.-C.; Huang S.-E.; Yang T.-H.; PO-CHENG HSU; Kuo C.-H.; Lin Y.-Y.; Lai W.-Y.; Kao C.-L. |
| 臺大學術典藏 |
2022-01-25T05:10:40Z |
High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C
|
Hsu C.-S.; Liu C.-J.; Liu C.-H.; Wang C.-C.; CHI-LING CHEN; Lai M.-Y.; Chen P.-J.; Kao J.-H.; Chen D.-S. |
| 臺大學術典藏 |
2022-01-25T05:10:38Z |
Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection
|
Hsu C.-S.; Liu C.-H.; Liu C.-J.; Wang C.-C.; CHI-LING CHEN; Lai M.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-25T05:10:34Z |
Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infection
|
Hsu C.-S.; Wang C.-C.; Wang P.-C.; Lin H.H.; Tseng T.-C.; Chen C.-H.; Su W.-C.; Liu C.-J.; CHI-LING CHEN; Lai M.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-25T05:07:26Z |
Impact of hepatitis B virus infection on metabolic profiles and modifying factors
|
Hsu C.-S.; Liu C.-H.; Wang C.-C.; Tseng T.-C.; Liu C.-J.; CHI-LING CHEN; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-25T05:07:26Z |
Serum hepatitis B virus-DNA levels correlate with long-term adverse outcomes in spontaneous hepatitis B e antigen seroconverters
|
Tseng T.-C.; Liu C.-J.; CHI-LING CHEN; Wang C.-C.; Su T.-H.; Kuo S.F.-T.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-25T05:07:26Z |
High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load
|
Tseng T.-C.; Liu C.-J.; Yang H.-C.; Su T.-H.; Wang C.-C.; CHI-LING CHEN; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-25T05:07:25Z |
Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load
|
Tseng T.-C.; Liu C.-J.; Yang H.-C.; Su T.-H.; Wang C.-C.; CHI-LING CHEN; Fang-Tzu Kuo S.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-25T05:07:24Z |
Young chronic hepatitis b patients with nucleos(t)ide analogue-induced hepatitis b e antigen seroconversion have a higher risk of HBV reactivation
|
Tseng T.-C.; Liu C.-J.; Su T.-H.; Yang H.-C.; Wang C.-C.; CHI-LING CHEN; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-25T05:07:23Z |
Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads
|
Tseng T.-C.; Liu C.-J.; Yang H.-C.; Su T.-H.; Wang C.-C.; CHI-LING CHEN; Hsu C.-A.; Fang-Tzu Kuo S.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-25T05:07:21Z |
Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers
|
Tseng T.-C.; Liu C.-J.; CHI-LING CHEN; Yang H.-C.; Su T.-H.; Wang C.-C.; Yang W.-T.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-25T03:25:22Z |
Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters
|
Tseng T.-C.; Liu C.-J.; Yang W.-T.; CHI-LING CHEN; Yang H.-C.; Su T.-H.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-25T03:25:18Z |
Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection
|
Tseng T.-C.; Liu C.-J.; CHI-LING CHEN; Yang W.-T.; Yang H.-C.; Su T.-H.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-25T03:25:17Z |
Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers
|
Tseng T.-C.; Liu C.-J.; Yang H.-C.; CHI-LING CHEN; Yang W.-T.; Tsai C.-S.; Kuo S.F.-T.; Verbree F.C.; Su T.-H.; Wang C.-C.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-25T03:25:15Z |
Hepatitis B surface antigen loss and hepatocellular carcinoma development in patients with dual hepatitis B and C infection
|
Yang W.-T.; Wu L.-W.; Tseng T.-C.; CHI-LING CHEN; Yang H.-C.; Su T.-H.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Liu C.-J.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-25T03:25:12Z |
Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
|
Su T.-H.; Hu T.-H.; Chen C.-Y.; Huang Y.-H.; Chuang W.-L.; Lin C.-C.; Wang C.-C.; Su W.-W.; Chen M.-Y.; Peng C.-Y.; Chien R.-N.; Huang Y.-W.; Wang H.-Y.; Lin C.-L.; Yang S.-S.; Chen T.-M.; Mo L.-R.; Hsu S.-J.; Tseng K.-C.; Hsieh T.-Y.; Suk F.-M.; Hu C.-T.; Bair M.-J.; Liang C.-C.; Lei Y.-C.; Tseng T.-C.; CHI-LING CHEN; Kao J.-H.; the C-TEAM study group; the Taiwan Liver Diseases Consortium |
| 臺大學術典藏 |
2022-01-25T03:25:10Z |
Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular Carcinoma
|
Tseng T.-C.; Liu C.-J.; Su T.-H.; Yang W.-T.; CHI-LING CHEN; Yang H.-C.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
